Clinical Trial Update: Semaglutide's Weight Loss Effects in Obesity [NA]

View source ↗

Summary

The document reports a clinical trial evaluating semaglutide for weight loss in obesity, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Obesity | NA | Status: NOT_YET_RECRUITING